SCHEMBL18847491

SCHEMBL18847491

c1cc(-c2cccc(-c3nc4ccccc4c4c3ccc3c5ccccc5oc34)c2)cc(-c2cn3ccccc3n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.46
▸ BACE2 Q9Y5Z0 3/20 0.46
▸ KDM4E B2RXH2 10/20 0.41
▸ ALDH1A1 P00352 10/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ RAB9A P51151 8/20 0.41
▸ SMN1; SMN2 Q16637 7/20 0.41
▸ NPC1 O15118 6/20 0.41
▸ POLB P06746 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ PTK2B Q14289 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ GFER P55789 2/20 0.40
▸ GAA P10253 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18847234 0.96 BACE1 (0.42) BACE1BACE2KDM4EALDH1A1KMT2A
SCHEMBL18847067 0.96 BACE1 (0.45) BACE1BACE2KDM4EALDH1A1KMT2A
SCHEMBL18847237 0.90 TLR9 (0.39) BACE1BACE2KDM4EALDH1A1KMT2A
SCHEMBL18847515 0.89 ALDH1A3 (0.47) KDM4EALDH1A1KMT2AHSD17B10RAB9A
SCHEMBL18846934 0.85 SCD (0.41) KDM4EALDH1A1RAB9ASMN1; SMN2NPC1
SCHEMBL18848095 0.84 RAB9A (0.40) KDM4EALDH1A1KMT2AMEN1HSD17B10
SCHEMBL18201096 0.84 BACE1 (0.51) BACE1BACE2KDM4EALDH1A1KMT2A
SCHEMBL15394202 0.83 RAB9A (0.48) BACE1BACE2KDM4EALDH1A1KMT2A
SCHEMBL18846855 0.81 ALDH1A3 (0.53) KDM4EALDH1A1KMT2AHSD17B10RAB9A
SCHEMBL15394637 0.81 BACE1 (0.45) BACE1BACE2KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 BACE1 804/4885BACE2 747/4885KDM4E 1869/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 BACE1 804/4885BACE2 747/4885KDM4E 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback